Medicine guide

TEVA-RASAGILINE

As listed in the register: TEVA-RASAGILINE

0.5 mg · tablet

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Made by
Teva Canada Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupPain, sleep, mood, epilepsy and the brainN04BD02

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byTeva Canada Limited
Active substanceRasagiline (Rasagiline Mesylate)
Used inPain, sleep, mood, epilepsy and the brain
Strength0.5 mg
Formtablet
ClassificationN04BD02 · Pain, sleep, mood, epilepsy and the brain
Routeoral
Dispensing (as stated by the register)PRESCRIPTION
StatusMarketed
MarketedYes, according to the register
DIN02418436
DPD drug code90300

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • tablet2 products

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.